Literature DB >> 6698292

Activity of enzymes related to carbohydrate metabolism in the HT 29 colon adenocarcinoma cell line and tumor.

C Denis, C Cortinovis, B Terrain, V Viallard, H Paris, J C Murat.   

Abstract

Activity of several enzymes of the glycogen and carbohydrate metabolism is studied in HT 29 colon adenocarcinoma cell line and in HT 29 tumors developed in nude mice, by reference to the normal human colon mucosa. Activity of glycogen synthase, glycogen phosphorylase, pyruvate kinase, fructose-1,6-diphosphatase, glucose-6-phosphate dehydrogenase and lactate dehydrogenase is found to be increased in both the cultured cells and the tumors. It indicates that the biochemical strategy of malignant cells, due to the neoplastic transformation process, involves specific changes in the carbohydrate metabolism of tumor as well as in vitro growing correspondent cell line.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698292     DOI: 10.1016/0020-711x(84)90055-7

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  4 in total

1.  Hormonal control of fructose 2,6-bisphosphate concentration in the HT29 human colon adenocarcinoma cell line. Alpha 2-adrenergic agonists counteract effect of vasoactive intestinal peptide.

Authors:  C Denis; H Paris; J C Murat
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

2.  Insulin controls key steps of carbohydrate metabolism in cultured HT29 colon cancer cells.

Authors:  T Babia; C Denis-Pouxviel; J C Murat; A M Gomez-Foix; V Trocheris; J J Guinovart; F Bosch
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

3.  The posttranslational processing of sucrase-isomaltase in HT-29 cells is a function of their state of enterocytic differentiation.

Authors:  G Trugnan; M Rousset; I Chantret; A Barbat; A Zweibaum
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

4.  Energy state in HT-29 cells is linked to differentiation.

Authors:  C J Graz; H M Cowley
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-04       Impact factor: 2.723

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.